In the most comprehensive of these studies, the authors identified 26 BRCA mutations (15 BRCA1 and 11 BRCA2) in 287 Greek breast/ovarian cancer families using dHPLC followed by direct sequencing [16]. This evidence concerns the gene BRCA2 and ovarian carcinoma.